Developments PharmaJet and Scancell forge alliance to develop and commercialize needle-free DNA vaccine for advanced melanoma Closely-held PharmaJet has announced a strategic partnership with Scancell Holdings (AIM:SCLP) to supply its Stratis Intramuscular (IM) Needle-free Injection System for delivery of Scancell’s advanced melanoma DNA... September 17, 2024